Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Brazil.
J Periodontol. 2011 Aug;82(8):1187-96. doi: 10.1902/jop.2011.100643. Epub 2011 Feb 2.
This study compares the levels of cytokines and bone-related factors in the gingival crevicular fluid (GCF) of systemically healthy patients with chronic periodontitis (CP); and better-controlled, and poorly controlled patients with type 2 diabetes and CP.
Thirty-seven patients with type 2 diabetes and CP and 20 systemically healthy patients with CP were enrolled in this study. The patients with diabetes mellitus were categorized as better-controlled (n = 17; HbA(1c) levels ≤8%) or poorly controlled (n = 20; glycated hemoglobin values >8%). Levels of tumor necrosis factor-α, interleukin (IL)-4, interferon (IFN)-γ, IL-23, IL-17, soluble receptor activator of nuclear factor-kappa B ligand (sRANKL), and osteoprotegerin (OPG) in GCF of diseased sites were analyzed by enzyme-linked immunosorbent assay.
Type 2 diabetes mellitus, as a whole, upregulates the levels of OPG, sRANKL, IFN-γ, IL-17, and IL-23 and downregulates the production of IL-4 in sites with CP (P <0.05). Better-controlled individuals exhibited the highest levels of IFN-γ, whereas poorly controlled patients presented the highest levels of IL-17 (P <0.05). There were no differences in the levels of tumor necrosis factor-α, OPG, and IL-23 among systemically healthy, better-controlled, and poorly controlled patients with diabetes (P >0.05).
Increased levels of proinflammatory cytokines and RANKL were observed in the GCF of patients with type 2 diabetes with CP, compared to patients without diabetes. In addition, poor or good glycemic status seems to modulate osteo-immunoinflammatory mediators in a different manner.
本研究比较了患有慢性牙周炎(CP)的系统健康患者、2 型糖尿病且 CP 控制较好的患者和 2 型糖尿病且 CP 控制较差的患者的龈沟液(GCF)中的细胞因子和与骨相关的因子水平。
本研究纳入了 37 例 2 型糖尿病且 CP 患者和 20 例系统健康的 CP 患者。糖尿病患者分为血糖控制较好(HbA1c 水平≤8%,n=17)和血糖控制较差(糖化血红蛋白值>8%,n=20)。通过酶联免疫吸附试验分析 GCF 中肿瘤坏死因子-α、白细胞介素(IL)-4、干扰素(IFN)-γ、IL-23、IL-17、可溶性核因子-kappa B 受体激活剂配体(sRANKL)和骨保护素(OPG)的水平。
总体而言,2 型糖尿病会上调 CP 部位的 OPG、sRANKL、IFN-γ、IL-17 和 IL-23 水平,并下调 IL-4 的产生(P<0.05)。血糖控制较好的个体表现出最高水平的 IFN-γ,而血糖控制较差的患者则表现出最高水平的 IL-17(P<0.05)。在系统健康、血糖控制较好和血糖控制较差的糖尿病患者中,肿瘤坏死因子-α、OPG 和 IL-23 的水平没有差异(P>0.05)。
与无糖尿病的 CP 患者相比,2 型糖尿病 CP 患者的 GCF 中观察到促炎细胞因子和 RANKL 水平升高。此外,较差或较好的血糖状态似乎以不同的方式调节骨免疫炎症介质。